BIOGEN AND COVID-19

At Biogen, we are committed to the health and well-being of those living with spinal muscular atrophy (SMA), now more than ever. During these uncertain times, we want you to know you can count on our continued commitment to the SMA community as we navigate this public health challenge together. 

As always, our SMA360º™* Team is here to support you.

You can contact us from 8:30 AM – 8:00 PM EST,

Monday through Friday at 1-844-4SPINRAZA (1-844-477-4672).

Your healthcare team is always your best source of information regarding your treatment.  Any decisions about treatment should be based on your specific condition and medical history after speaking with your healthcare provider. Please speak to your provider if you have any questions or concerns, including questions about SPINRAZA and COVID-19.   

For more information about Biogen’s response to the novel coronavirus pandemic, please visit https://www.biogen.com/en_us/covid-19-updates.html

*SMA360° services from Biogen are available only to those who have been prescribed SPINRAZA. SMA360° is intended for US residents only.

IMPORTANT SAFETY INFORMATION

Increased risk of bleeding complications has been observed after administration of similar medicines. Your healthcare provider should perform blood tests before you start treatment with SPINRAZA and before each dose to monitor for signs of these risks. Seek medical attention if unexpected bleeding occurs.

Increased risk of kidney damage, including potentially fatal acute inflammation of the kidney, has been observed after administration of similar medicines. Your healthcare provider should perform urine testing before you start treatment with SPINRAZA and before each dose to monitor for signs of this risk.

The most common side effects of SPINRAZA include lower respiratory infection, fever, constipation, headache, vomiting, back pain, and post-lumbar puncture syndrome.

These are not all of the possible side effects of SPINRAZA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking SPINRAZA, tell your healthcare provider if you are pregnant or plan to become pregnant.

Please see full Prescribing Information.

As a courtesy, our full Prescribing Information is also available en Español. For prescribing decisions, please refer to official approved labeling.

This information is not intended to replace discussions with your healthcare provider.


INDICATION

SPINRAZA is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.